97 related articles for article (PubMed ID: 25970747)
1. Qualitative Profiling of Polyglucose Degradation Products in Peritoneal Dialysis Fluids.
Gensberger S; Knabner C; Waibel R; Huppert J; Pischetsrieder M
Anal Chem; 2015 Jun; 87(12):6103-11. PubMed ID: 25970747
[TBL] [Abstract][Full Text] [Related]
2. Quantification of reactive carbonyl compounds in icodextrin-based peritoneal dialysis fluids by combined UHPLC-DAD and -MS/MS detection.
Gensberger-Reigl S; Huppert J; Pischetsrieder M
J Pharm Biomed Anal; 2016 Jan; 118():132-138. PubMed ID: 26540628
[TBL] [Abstract][Full Text] [Related]
3. 3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: identification, quantification by HPLC/DAD/MSMS and its pathway of formation.
Mittelmaier S; Fünfrocken M; Fenn D; Pischetsrieder M
Anal Bioanal Chem; 2011 Feb; 399(4):1689-97. PubMed ID: 21136045
[TBL] [Abstract][Full Text] [Related]
4. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids.
Distler L; Georgieva A; Kenkel I; Huppert J; Pischetsrieder M
Chem Res Toxicol; 2014 Aug; 27(8):1421-30. PubMed ID: 25033248
[TBL] [Abstract][Full Text] [Related]
5. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
6. Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC/DAD/MSMS.
Mittelmaier S; Fünfrocken M; Fenn D; Fichert T; Pischetsrieder M
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):877-82. PubMed ID: 20189892
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the six major α-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC/DAD/MSMS.
Mittelmaier S; Fünfrocken M; Fenn D; Berlich R; Pischetsrieder M
Anal Bioanal Chem; 2011 Sep; 401(4):1183-93. PubMed ID: 21725830
[TBL] [Abstract][Full Text] [Related]
8. Chemical and physiological relevance of glucose degradation products in peritoneal dialysis.
Mittelmaier S; Niwa T; Pischetsrieder M
J Ren Nutr; 2012 Jan; 22(1):181-5. PubMed ID: 22200439
[TBL] [Abstract][Full Text] [Related]
9. Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.
Ishikawa N; Miyata T; Ueda Y; Inagi R; Izuhara Y; Yuzawa H; Onogi H; Nishina M; Nangaku M; Van Ypersele De Strihou C; Kurokawa K
Kidney Int; 2003 Jan; 63(1):331-9. PubMed ID: 12472800
[TBL] [Abstract][Full Text] [Related]
10. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.
Schalkwijk CG; Posthuma N; ten Brink HJ; ter Wee PM; Teerlink T
Perit Dial Int; 1999; 19(4):325-33. PubMed ID: 10507813
[TBL] [Abstract][Full Text] [Related]
11. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes.
Nilsson-Thorell CB; Muscalu N; Andrén AH; Kjellstrand PT; Wieslander AP
Perit Dial Int; 1993; 13(3):208-13. PubMed ID: 8369351
[TBL] [Abstract][Full Text] [Related]
12. Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis.
Tauer A; Bender TO; Fleischmann EH; Niwa T; Jörres A; Pischetsrieder M
Mol Nutr Food Res; 2005 Jul; 49(7):710-5. PubMed ID: 15915443
[TBL] [Abstract][Full Text] [Related]
13. How to avoid glucose degradation products in peritoneal dialysis fluids.
Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
Perit Dial Int; 2006; 26(4):490-7. PubMed ID: 16881345
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids.
Frischmann M; Spitzer J; Fünfrocken M; Mittelmaier S; Deckert M; Fichert T; Pischetsrieder M
Biomed Chromatogr; 2009 Aug; 23(8):843-51. PubMed ID: 19353694
[TBL] [Abstract][Full Text] [Related]
15. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids.
Wieslander A; Linden T; Musi B; Carlsson O; Deppisch R
Perit Dial Int; 2000; 20 Suppl 5():S23-7. PubMed ID: 11229608
[TBL] [Abstract][Full Text] [Related]
16. Degradation in peritoneal dialysis fluids may be avoided by using low pH and high glucose concentration.
Kjellstrand P; Martinson E; Wieslander A; Kjellstrand K; Jeppsson E; Svensson E; Järkelid L; Linden T; Olsson LF
Perit Dial Int; 2001; 21(4):338-44. PubMed ID: 11587395
[TBL] [Abstract][Full Text] [Related]
17. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis.
Linden T; Forsbäck G; Deppisch R; Henle T; Wieslander A
Perit Dial Int; 1998; 18(3):290-3. PubMed ID: 9663893
[TBL] [Abstract][Full Text] [Related]
18. Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids.
Gensberger-Reigl S; Weigel I; Stützer J; Auditore A; Nikolaus T; Pischetsrieder M
Sci Rep; 2022 Mar; 12(1):4268. PubMed ID: 35277529
[TBL] [Abstract][Full Text] [Related]
19. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis.
Wieslander AP; Deppisch R; Svensson E; Forsbäck G; Speidel R; Rippe B
Perit Dial Int; 1995; 15(2):158-64. PubMed ID: 7612737
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis.
Linden T; Cohen A; Deppisch R; Kjellstrand P; Wieslander A
Kidney Int; 2002 Aug; 62(2):697-703. PubMed ID: 12110035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
